These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33423943)

  • 1. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
    Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
    Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
    Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
    Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
    Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
    Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?
    Hopstaken JS; Bomers JGR; Sedelaar MJP; Valerio M; Fütterer JJ; Rovers MM
    Eur Urol; 2022 Jan; 81(1):5-33. PubMed ID: 34489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
    Ramsay C; Pickard R; Robertson C; Close A; Vale L; Armstrong N; Barocas DA; Eden CG; Fraser C; Gurung T; Jenkinson D; Jia X; Lam TB; Mowatt G; Neal DE; Robinson MC; Royle J; Rushton SP; Sharma P; Shirley MD; Soomro N
    Health Technol Assess; 2012; 16(41):1-313. PubMed ID: 23127367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
    Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
    Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
    Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
    Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
    Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
    Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
    Van den Broeck T; Oprea-Lager D; Moris L; Kailavasan M; Briers E; Cornford P; De Santis M; Gandaglia G; Gillessen Sommer S; Grummet JP; Grivas N; Lam TBL; Lardas M; Liew M; Mason M; O'Hanlon S; Pecanka J; Ploussard G; Rouviere O; Schoots IG; Tilki D; van den Bergh RCN; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Mottet N
    Eur Urol; 2021 Nov; 80(5):531-545. PubMed ID: 33962808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review.
    Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
    Prostate Cancer Prostatic Dis; 2024 Dec; 27(4):623-634. PubMed ID: 37507479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
    Moris L; Gandaglia G; Vilaseca A; Van den Broeck T; Briers E; De Santis M; Gillessen S; Grivas N; O'Hanlon S; Henry A; Lam TB; Lardas M; Mason M; Oprea-Lager D; Ploussard G; Rouviere O; Schoots IG; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Grummet JP; Tilki D; van den Bergh RCN; Cornford P; Mottet N
    Eur Urol Focus; 2022 May; 8(3):690-700. PubMed ID: 34147405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular-targeted Photodynamic Therapy in Unilateral Low-risk Prostate Cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical Prostatectomy.
    Flegar L; Buerk B; Proschmann R; Propping S; Groeben C; Baunacke M; Herout R; Huber J; Thomas C; Borkowetz A
    Eur Urol Focus; 2022 Jan; 8(1):121-127. PubMed ID: 33602642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
    Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
    J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
    Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.
    Peinemann F; Grouven U; Bartel C; Sauerland S; Borchers H; Pinkawa M; Heidenreich A; Lange S
    Eur Urol; 2011 Nov; 60(5):881-93. PubMed ID: 21763066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.